TIGIT and breast carcinoma: To determine whether BGB-A1217 can activate NK cells, purified NK cells co-cultured with a human breast cancer cell line SK-BR-3 (expressing high level of PVR) in the presence of TIGIT mAbs, and NK cell activation was determined by measuring an NK cell degranulation marker CD107a by flow cytometry (Figure 4A).